Related Experiment Video
Updated: May 30, 2025
07:54
Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
19.6K
Enhancing Obstructive Sleep Apnea Screening and Nocturia Treatment: A Quality Improvement Study
K Marie Douglass1, Katharina Laus2, Samantha DeAndrade3
1From the Division of Urogynecology & Reconstructive Pelvic Surgery, Department of OB/GYN, Harbor-UCLA Medical Center, Torrance CA.
Urogynecology (Philadelphia, Pa.)
|January 27, 2025
Summary
Screening for obstructive sleep apnea (OSA) in urogynecology patients with nocturia is feasible and identifies a high prevalence of OSA. Treatment improved nocturia symptoms, highlighting the need for better adherence and access to care.
Area of Science:
- Urogynecology
- Sleep Medicine
- Public Health
Background:
- Obstructive sleep apnea (OSA) is frequently undiagnosed in urogynecology patients experiencing nocturia.
- Treating OSA can potentially alleviate nocturia symptoms.
Purpose of the Study:
- To evaluate the impact of universal obstructive sleep apnea (OSA) screening in a urogynecology clinic.
- To assess screening rates, OSA prevalence in patients with nocturia, and symptom improvement post-treatment.
Main Methods:
- An observational quality improvement study was conducted at a urogynecology clinic.
- The STOP-BANG questionnaire was used for universal screening of new patients with nocturia.
- Data collected included screening rates, sleep study completion, OSA diagnosis, treatment adherence, and symptom changes.
Main Results:
- Eighty-seven percent of eligible patients were screened, with increasing rates over 18 months.
- 20.2% of screened patients tested positive for OSA, with 80.6% ultimately diagnosed.
- Despite low treatment adherence, patients using treatment reported symptom improvement.
Conclusions:
- Implementing OSA screening in urogynecology clinics is effective for addressing nocturia.
- Multidisciplinary approaches and systems-level changes are crucial for improving OSA testing and treatment adherence, addressing access barriers.
